This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Giavedoni, L. Articles by Yilma, T. Search for Related Content PubMed PubMed Citation Articles by Giavedoni, L. Articles by Yilma, T.

 Previous Article  |  Next Article 

J. Virol., Feb 1997, 866-872, Vol 71, No. 2
Copyright © 1997, American Society for Microbiology

Expression of gamma interferon by simian immunodeficiency virus increases attenuation and reduces postchallenge virus load in vaccinated rhesus macaques

L Giavedoni, S Ahmad, L Jones and T Yilma
International Laboratory of Molecular Biology for Tropical Disease Agents, Department of Veterinary Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California, Davis 95616, USA.

Simian immunodeficiency virus (SIV) infection of macaques is a model for human immunodeficiency virus (HIV) infection. We have previously reported the construction and characterization of an SIV vector with a deletion in the nef gene (SIV(delta nef)) and expressing gamma interferon (SIV(HyIFN)) (L. Giavedoni and T. Yilma, J. Virol. 70:2247- 2251, 1996). We now show that rhesus macaques vaccinated with SIV(HyIFN) have a lower viral load than a group similarly immunized with SIV(delta nef). Viral loads remained low in the SIV(HyIFN)- vaccinated group even though SIV expressing gamma interferon could not be isolated after 6 weeks postimmunization in these animals. All immunized and two naive control macaques became infected when challenged with virulent SIV(mac251), at 25 weeks postvaccination. In contrast to the two naive controls that died by 12 and 18 weeks postchallenge, all vaccinated animals remained healthy for more than 32 weeks. In addition, postchallenge cell-associated virus load was significantly lower in SIV(HyIFN)-immunized animals than in the group vaccinated with SIV(delta nef). These findings indicate that cytokine- expressing viruses can provide a novel approach for development of safe and efficacious live attenuated vaccines for AIDS.

This article has been cited by other articles:

• Peng, Y., Lin, F.-c., Verardi, P. H., Jones, L. A., McChesney, M. B., Yilma, T. D. (2007). Pseudotyped Single-Cycle Simian Immunodeficiency Viruses Expressing Gamma Interferon Augment T-Cell Priming Responses In Vitro. J. Virol. 81: 2187-2195 [Abstract] [Full Text]  
• Zhou, X., Vink, M., Klaver, B., Verhoef, K., Marzio, G., Das, A. T., Berkhout, B. (2006). The Genetic Stability of a Conditional Live HIV-1 Variant Can Be Improved by Mutations in the Tet-On Regulatory System That Restrain Evolution. J. Biol. Chem. 281: 17084-17091 [Abstract] [Full Text]  
• Hodara, V. L., Velasquillo, M. C., Parodi, L. M., Giavedoni, L. D. (2005). Expression of CD154 by a Simian Immunodeficiency Virus Vector Induces Only Transitory Changes in Rhesus Macaques. J. Virol. 79: 4679-4690 [Abstract] [Full Text]  
• Ozwara, H., Langermans, J. A. M., Kocken, C. H. M., van der Wel, A., van der Meide, P. H., Vervenne, R. A. W., Mwenda, J. M., Thomas, A. W. (2003). Transfected Plasmodium knowlesi Produces Bioactive Host Gamma Interferon: a New Perspective for Modulating Immune Responses to Malaria Parasites. Infect. Immun. 71: 4375-4381 [Abstract] [Full Text]  
• Chang, T. L.-Y., Mosoian, A., Pine, R., Klotman, M. E., Moore, J. P. (2002). A Soluble Factor(s) Secreted from CD8+ T Lymphocytes Inhibits Human Immunodeficiency Virus Type 1 Replication through STAT1 Activation. J. Virol. 76: 569-581 [Abstract] [Full Text]  
• Raggo, C., Habermehl, M., Babiuk, L. A., Griebel, P. (2000). The in vivo effects of recombinant bovine herpesvirus-1 expressing bovine interferon-{gamma}. J. Gen. Virol. 81: 2665-2673 [Abstract] [Full Text]  
• Giavedoni, L. D., Velasquillo, M. C., Parodi, L. M., Hubbard, G. B., Hodara, V. L. (2000). Cytokine Expression, Natural Killer Cell Activation, and Phenotypic Changes in Lymphoid Cells from Rhesus Macaques during Acute Infection with Pathogenic Simian Immunodeficiency Virus. J. Virol. 74: 1648-1657 [Abstract] [Full Text]  
• Sawai, E. T., Hamza, M. S., Ye, M., Shaw, K. E. S., Luciw, P. A. (2000). Pathogenic Conversion of Live Attenuated Simian Immunodeficiency Virus Vaccines Is Associated with Expression of Truncated Nef. J. Virol. 74: 2038-2045 [Abstract] [Full Text]  
• Gauduin, M.-C., Glickman, R. L., Ahmad, S., Yilma, T., Johnson, R. P. (1999). Immunization with live attenuated simian immunodeficiency virus induces strong type 1 T helper responses and beta -chemokine production. Proc. Natl. Acad. Sci. USA 96: 14031-14036 [Abstract] [Full Text]  
• Bukreyev, A., Whitehead, S. S., Bukreyeva, N., Murphy, B. R., Collins, P. L. (1999). Interferon gamma  expressed by a recombinant respiratory syncytial virus attenuates virus replication in mice without compromising immunogenicity. Proc. Natl. Acad. Sci. USA 96: 2367-2372 [Abstract] [Full Text]  
• Lewis, M. G., Yalley-Ogunro, J., Greenhouse, J. J., Brennan, T. P., Jiang, J. B., VanCott, T. C., Lu, Y., Eddy, G. A., Birx, D. L. (1999). Limited Protection from a Pathogenic Chimeric Simian-Human Immunodeficiency Virus Challenge following Immunization with Attenuated Simian Immunodeficiency Virus. J. Virol. 73: 1262-1270 [Abstract] [Full Text]  
• Gundlach, B. R., Reiprich, S., Sopper, S., Means, R. E., Dittmer, U., Matz-Rensing, K., Stahl-Hennig, C., Uberla, K. (1998). Env-Independent Protection Induced by Live, Attenuated Simian Immunodeficiency Virus Vaccines. J. Virol. 72: 7846-7851 [Abstract] [Full Text]  
• Hosie, M. J., Flynn, J. N., Rigby, M. A., Cannon, C., Dunsford, T., Mackay, N. A., Argyle, D., Willett, B. J., Miyazawa, T., Onions, D. E., Jarrett, O., Neil, J. C. (1998). DNA Vaccination Affords Significant Protection against Feline Immunodeficiency Virus Infection without Inducing Detectable Antiviral Antibodies. J. Virol. 72: 7310-7319 [Abstract] [Full Text]